Skip to main content
OpenTrials

Clinical trial condition

Wilms Tumor

Explore clinical trials studying Wilms Tumor. Study availability and eligibility vary by location and protocol.

57 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Wilms Tumor trial results

Completed

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

NCT02982941

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Desmoplastic Small Round Cell Tumor, Ewing Sarcoma, +33 more
Locations
  • Lucile Packard Children's Hospital, Stanford Palo Alto, California, United States
  • National Cancer Institute, Center for Cancer Research Bethesda, Maryland, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details
Completed

Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma

NCT02452554

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +45 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 69 locations
View Trial Details
Completed

iCAT for Recurrent/Refractory/HR Solid Tumors

NCT01853345

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Female Urogenital Diseases, +29 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Children's National Medical center Washington D.C., District of Columbia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions